Product Code: TMRGL84937
The report provides revenue of the global nanorobotics in medicine market for the period 2017-2031, considering 2021 as the base year and 2031 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global nanorobotics in medicine market from 2022 to 2031.
The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players' product literature, annual reports, press releases, and relevant documents to understand the nanorobotics in medicine market.
The report delves into the competitive landscape of the global nanorobotics in medicine market. Key players operating in the global nanorobotics in medicine market have been identified and each one of these has been profiled, in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are attributes of players in the global nanorobotics in medicine market profiled in this report.
Table of Contents
1. Preface
- 1.1. Market Definition and Scope
- 1.2. Market Segmentation
- 1.3. Key Research Objectives
- 1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary: Global Nanorobotics in Medicine Market
4. Market Overview
- 4.1. Introduction
- 4.1.1. Definition
- 4.1.2. Industry Evolution/Developments
- 4.2. Overview
- 4.3. Market Dynamics
- 4.3.1. Drivers
- 4.3.2. Restraints
- 4.3.3. Opportunities
- 4.4. Global Nanorobotics in Medicine Market Analysis and Forecast, 2017 - 2031
5. Key Insights
- 5.1. Technological Advancements
- 5.2. Brand Analysis of Key Products
- 5.3. Key Industry Events (Mergers, Acquisitions, Collaborations, Approvals, etc.)
- 5.4. COVID-19 Pandemic Impact on Industry (Value Chain and Short/Mid/Long-term Impact)
6. Global Nanorobotics in Medicine Market Analysis and Forecast, by Product Type
- 6.1. Introduction & Definition
- 6.2. Key Findings/Developments
- 6.3. Market Value Forecast, by Product Type, 2017 - 2031
- 6.3.1. Nanomanipulator
- 6.3.1.1. Electron Microscopy
- 6.3.1.2. Scanning Probe Microscopy
- 6.3.2. Bio-nanorobotics
- 6.3.3. Magnetically Guided
- 6.3.4. Bacteria-based
- 6.4. Market Attractiveness, by Product Type
7. Global Nanorobotics in Medicine Market Analysis and Forecast, by Application
- 7.1. Introduction & Definition
- 7.2. Key Findings/Developments
- 7.3. Market Value Forecast, by Application, 2017 - 2031
- 7.3.1. Nanomedicine
- 7.3.2. Biomedical
- 7.3.3. Drug Delivery
- 7.3.4. Medical Imaging
- 7.3.5. Others
- 7.4. Market Attractiveness, by Application
8. Global Nanorobotics in Medicine Market Analysis and Forecast, by End-user
- 8.1. Introduction & Definition
- 8.2. Key Findings/Developments
- 8.3. Market Value Forecast, by End-user, 2017 - 2031
- 8.3.1. Pharmaceutical Industry
- 8.3.2. Research Institute
- 8.3.3. Hospitals
- 8.3.4. Others
- 8.4. Market Attractiveness, by End-user
9. Global Nanorobotics in Medicine Market Analysis and Forecast, by Region
- 9.1. Key Findings
- 9.2. Market Value Forecast, by Region
- 9.2.1. North America
- 9.2.2. Europe
- 9.2.3. Asia Pacific
- 9.2.4. Latin America
- 9.2.5. Middle East & Africa
- 9.3. Market Attractiveness, by Country/Region
10. North America Nanorobotics in Medicine Market Analysis and Forecast
- 10.1. Introduction
- 10.2. Market Value Forecast, by Product Type, 2017 - 2031
- 10.2.1. Nanomanipulator
- 10.2.1.1. Electron Microscopy
- 10.2.1.2. Scanning Probe Microscopy
- 10.2.2. Bio-nanorobotics
- 10.2.3. Magnetically Guided
- 10.2.4. Bacteria-based
- 10.3. Market Value Forecast, by Application, 2017 - 2031
- 10.3.1. Nanomedicine
- 10.3.2. Biomedical
- 10.3.3. Drug Delivery
- 10.3.4. Medical Imaging
- 10.3.5. Others
- 10.4. Market Value Forecast, by End-user, 2017 - 2031
- 10.4.1. Pharmaceutical Industry
- 10.4.2. Research Institute
- 10.4.3. Hospitals
- 10.4.4. Others
- 10.5. Market Value Forecast, by Country, 2017 - 2031
- 10.5.1. U.S.
- 10.5.2. Canada
- 10.6. Market Attractiveness Analysis
- 10.6.1. By Product Type
- 10.6.2. By Application
- 10.6.3. By End-user
- 10.6.4. By Country
11. Europe Nanorobotics in Medicine Market Analysis and Forecast
- 11.1. Introduction
- 11.2. Market Value Forecast, by Product Type, 2017 - 2031
- 11.2.1. Nanomanipulator
- 11.2.1.1. Electron Microscopy
- 11.2.1.2. Scanning Probe Microscopy
- 11.2.2. Bio-nanorobotics
- 11.2.3. Magnetically Guided
- 11.2.4. Bacteria-based
- 11.3. Market Value Forecast, by Application, 2017 - 2031
- 11.3.1. Nanomedicine
- 11.3.2. Biomedical
- 11.3.3. Drug Delivery
- 11.3.4. Medical Imaging
- 11.3.5. Others
- 11.4. Market Value Forecast, by End-user, 2017 - 2031
- 11.4.1. Pharmaceutical Industry
- 11.4.2. Research Institute
- 11.4.3. Hospitals
- 11.4.4. Others
- 11.5. Market Value Forecast, by Country/Sub-region, 2017 - 2031
- 11.5.1. Germany
- 11.5.2. U.K.
- 11.5.3. France
- 11.5.4. Spain
- 11.5.5. Italy
- 11.5.6. Rest of Europe
- 11.6. Market Attractiveness Analysis
- 11.6.1. By Product Type
- 11.6.2. By Application
- 11.6.3. By End-user
- 11.6.4. By Country/Sub-region
12. Asia Pacific Nanorobotics in Medicine Market Analysis and Forecast
- 12.1. Introduction
- 12.2. Market Value Forecast, by Product Type, 2017 - 2031
- 12.2.1. Nanomanipulator
- 12.2.1.1. Electron Microscopy
- 12.2.1.2. Scanning Probe Microscopy
- 12.2.2. Bio-nanorobotics
- 12.2.3. Magnetically Guided
- 12.2.4. Bacteria-based
- 12.3. Market Value Forecast, by Application, 2017 - 2031
- 12.3.1. Nanomedicine
- 12.3.2. Biomedical
- 12.3.3. Drug Delivery
- 12.3.4. Medical Imaging
- 12.3.5. Others
- 12.4. Market Value Forecast, by End-user, 2017 - 2031
- 12.4.1. Pharmaceutical Industry
- 12.4.2. Research Institute
- 12.4.3. Hospitals
- 12.4.4. Others
- 12.5. Market Value Forecast, by Country/Sub-region, 2017 - 2031
- 12.5.1. China
- 12.5.2. Japan
- 12.5.3. India
- 12.5.4. Australia & New Zealand
- 12.5.5. Rest of Asia Pacific
- 12.6. Market Attractiveness Analysis
- 12.6.1. By Product Type
- 12.6.2. By Application
- 12.6.3. By End-user
- 12.6.4. By Country/Sub-region
13. Latin America Nanorobotics in Medicine Market Analysis and Forecast
- 13.1. Introduction
- 13.2. Market Value Forecast, by Product Type, 2017 - 2031
- 13.2.1. Nanomanipulator
- 13.2.1.1. Electron Microscopy
- 13.2.1.2. Scanning Probe Microscopy
- 13.2.2. Bio-nanorobotics
- 13.2.3. Magnetically Guided
- 13.2.4. Bacteria-based
- 13.3. Market Value Forecast, by Application, 2017 - 2031
- 13.3.1. Nanomedicine
- 13.3.2. Biomedical
- 13.3.3. Drug Delivery
- 13.3.4. Medical Imaging
- 13.3.5. Others
- 13.4. Market Value Forecast, by End-user, 2017 - 2031
- 13.4.1. Pharmaceutical Industry
- 13.4.2. Research Institute
- 13.4.3. Hospitals
- 13.4.4. Others
- 13.5. Market Value Forecast, by Country/Sub-region, 2017 - 2031
- 13.5.1. Brazil
- 13.5.2. Mexico
- 13.5.3. Rest of Latin America
- 13.6. Market Attractiveness Analysis
- 13.6.1. By Product Type
- 13.6.2. By Application
- 13.6.3. By End-user
- 13.6.4. By Country/Sub-region
14. Middle East & Africa Nanorobotics in Medicine Market Analysis and Forecast
- 14.1. Introduction
- 14.2. Market Value Forecast, by Product Type, 2017 - 2031
- 14.2.1. Nanomanipulator
- 14.2.1.1. Electron Microscopy
- 14.2.1.2. Scanning Probe Microscopy
- 14.2.2. Bio-nanorobotics
- 14.2.3. Magnetically Guided
- 14.2.4. Bacteria-based
- 14.3. Market Value Forecast, by Application, 2017 - 2031
- 14.3.1. Nanomedicine
- 14.3.2. Biomedical
- 14.3.3. Drug Delivery
- 14.3.4. Medical Imaging
- 14.3.5. Others
- 14.4. Market Value Forecast, by End-user, 2017 - 2031
- 14.4.1. Pharmaceutical Industry
- 14.4.2. Research Institute
- 14.4.3. Hospitals
- 14.4.4. Others
- 14.5. Market Value Forecast, by Country/Sub-region, 2017 - 2031
- 14.5.1. GCC Countries
- 14.5.2. South Africa
- 14.5.3. Rest of Middle East & Africa
- 14.6. Market Attractiveness Analysis
- 14.6.1. By Product Type
- 14.6.2. By Application
- 14.6.3. By End-user
- 14.6.4. By Country/Sub-region
15. Competition Landscape
- 15.1. Market Player - Competition Matrix (by tier and size of companies)
- 15.2. Market Share Analysis, by Company, 2021
- 15.3. Company Profiles
- 15.3.1. Imina Technologies SA
- 15.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)
- 15.3.1.2. Product Portfolio
- 15.3.1.3. SWOT Analysis
- 15.3.1.4. Strategic Overview
- 15.3.2. Thermo Fisher Scientific, Inc.
- 15.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)
- 15.3.2.2. Product Portfolio
- 15.3.2.3. SWOT Analysis
- 15.3.2.4. Strategic Overview
- 15.3.3. Oxford Instruments plc
- 15.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)
- 15.3.3.2. Product Portfolio
- 15.3.3.3. SWOT Analysis
- 15.3.3.4. Strategic Overview
- 15.3.4. Klocke Nanotechnik GmbH
- 15.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)
- 15.3.4.2. Product Portfolio
- 15.3.4.3. SWOT Analysis
- 15.3.4.4. Strategic Overview
- 15.3.5. Kleindiek Nanotechnik GmbH
- 15.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)
- 15.3.5.2. Product Portfolio
- 15.3.5.3. SWOT Analysis
- 15.3.5.4. Strategic Overview
- 15.3.6. SmarAct GmbH
- 15.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)
- 15.3.6.2. Product Portfolio
- 15.3.6.3. SWOT Analysis
- 15.3.6.4. Strategic Overview
- 15.3.7. Nanonics Imaging Ltd.
- 15.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)
- 15.3.7.2. Product Portfolio
- 15.3.7.3. SWOT Analysis
- 15.3.7.4. Strategic Overview
- 15.3.8. Hummingbird Scientific
- 15.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)
- 15.3.8.2. Product Portfolio
- 15.3.8.3. SWOT Analysis
- 15.3.8.4. Strategic Overview
- 15.3.9. Hitachi, Ltd.
- 15.3.9.1. Company Overview (HQ, Business Segments, Employee Strength)
- 15.3.9.2. Product Portfolio
- 15.3.9.3. SWOT Analysis
- 15.3.9.4. Strategic Overview